
@ShahidNShah
Screening for neurodegenerative disorders could help clinicians delay their onset by helping patients make lifestyle changes.
Researchers from Moorfields Eye Hospital and University College London have harnessed artificial intelligence (AI) technology to identify markers in eye scans that can predict the presence of Parkinson's disease, on average, seven years before clinical symptoms become apparent. The study, published in Neurology, employed AI to analyze retinal images obtained through optical coherence tomography (OCT) scans. This AI-powered analysis, drawing on extensive datasets, detected abnormalities indicative of Parkinson's, allowing for early intervention strategies. The breakthrough not only highlights the potential of AI-driven "oculomics" in identifying neurodegenerative disorders like Parkinson's but also emphasizes the eye's role as a gateway to holistic health insights. This emerging field could enable individuals to make lifestyle adjustments to delay disease onset and clinicians to mitigate the impact of such conditions.
Read on healthcareitnews.com
Continue reading at healthcareitnews.com
Diagnostic testing can play an important role in public health by stopping the dangerous squandering of effective medicines that are in short supply, says David Persing, chief medical and scientific …
Posted Aug 25, 2023 Molecular Diagnostic Techniques Pharmacy Solutions
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Mar 13, 2025 at 1:40pm